Cargando…
Clinical parameters affecting multipotent adult progenitor cells in vitro
BACKGROUND: Human multipotent adult progenitor cells (MAPC®) are an emerging therapy for traumatic brain injury (TBI); however, clinically translating a therapy involves overcoming many factors in vivo which are not present in pre-clinical testing. In this study we examined clinical parameters in vi...
Autores principales: | Jackson, Margaret L., Ruppert, Katherine A., Kota, Daniel J., Prabhakara, Karthik S., Hetz, Robert A., Aertker, Benjamin M., Bedi, Supinder, Mays, Robert W., Olson, Scott D., Cox, Charles S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812213/ https://www.ncbi.nlm.nih.gov/pubmed/31667385 http://dx.doi.org/10.1016/j.heliyon.2019.e02532 |
Ejemplares similares
-
Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury
por: Bedi, Supinder S., et al.
Publicado: (2018) -
Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population
por: Walker, Peter A, et al.
Publicado: (2012) -
High-resolution and differential analysis of rat microglial markers in traumatic brain injury: conventional flow cytometric and bioinformatics analysis
por: Toledano Furman, Naama, et al.
Publicado: (2020) -
Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations
por: Gottlieb, Assaf, et al.
Publicado: (2022) -
Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells
por: Ravanidis, Stylianos, et al.
Publicado: (2017)